Juvelook is a hybrid filler that combines the immediate filling effect resulting from the use of HA hyaluronic acid and long-term stimulation of collagen production, all thanks to the use of polylactic acid PDLLA (Poly D, L - lactide). The product has been designed as a filler that works over time with a concentration of 42.5 mg of PDLLA polylactic acid and 7.5 mg of non-cross-linked hyaluronic acid.
Juvelook, thanks to the patented manufacturing technology, patent: No. 10-1481441, No. 10-1725279 has unique properties: long-lasting effectiveness and an increased safety profile.
Juvelook Mechanism of Action:
1. Physical support
Immediately after injection, Juvelook finds its place in the tissues and fills them with non-cross-linked hyaluronic acid. Due to their properties, microparticles of polylactic acid provide cohesiveness to the HA hydrogel, preventing its displacement.
Two weeks after administration, when hyaluronic acid begins to hydrolyze, PLA microparticles intensively support collagen production and improve skin elasticity, firmness and thickness. From this turning point, an advantage in the action of PLA begins, resulting in long-term production of collagen and elastin.
After 6 months of administration, you can see the final and unique result of using Juvelook, the product then gradually biodegrades
and restores the skin's volume from physical stabilization to newly synthesized collagen fibers that sustain the natural effect over time.
No lumps or massaging - are there lumps after the Juvelook treatment after administering the product?
Juvelook, thanks to the patented production technology, eliminates the risk of the formation of subcutaneous lumps formed with the use of traditional PLLA.
Patent: No. 10-1481441 - this is a method of producing polymer microparticles with a network structure
Patent: No. 10-1725279 - it is a process of obtaining polylactic acid microparticles by spraying - spherical, porous shape.
Effects - how long do you see the effects after the Juvelook series?
The effects last for at least 24 months from the end of the treatment series.
Treatment series - how often should I administer Juvelook?
A correct series of treatments with Juvelook consists of 2 to 3 treatments performed at intervals of 6-8 weeks. Manufacturer's recommendation: a booster treatment is recommended after two years.
Method of administration - how is Juvelook given?
The product is administered with a thin 27G cannula in the area of the lower eyelid, tear valley or with thin needles, e.g. 31G, performing mesotherapy in the lower part of the dermis to a depth of about 1.7 mm.
The effects of Juvelook therapy - what are the effects of Juvelook?
Juvelook is one of the most effective in aesthetic medicine stimulants for the production of collagen, i.e. protein, which is responsible for the healthy and youthful appearance of the skin, for its hydration, improvement of skin firmness and elasticity!
Thanks to the combination of PDLLA polylactic acid with HA hyaluronic acid, we get an immediate effect, visible immediately after the treatment. The filling is maintained until the production of new collagen by polylactic acid begins to dominate.
What makes Juvelook unique? Why is Juvelook so popular?
• the world's only polylactic acid for use in the eye area, mesotherapy of the face, neck and neckline
• Juvelook has the ability to stimulate collagen production in the strongest possible way and restore youthful appearance in a gradual and natural way - no artificial effect!
• no need to massage the places where the product was applied
Application - how is Juvelook used? Which zones can be treated with the Juvelook?
Due to the moderate concentration of 42.5 mg polylactic acid and 7.5 mg hyaluronic acid, Juvelook is intended for the revitalization of large areas of the skin.
long-lasting illumination of the skin
regeneration of the eye area
tear valley reduction
brightening of shadows under the eyes
reduction of mimic wrinkles
improvement of skin tension
skin nourishment and regeneration
Where is Juvelook served? What areas is Juvelook used in?
Juvelook can be applied to the delicate eye area (tear valley, lower eyelids), forehead, the rest of the face, especially the lower floor, décolleté and neck.
The product is designed to act as a filler over time
with a concentration of 42.5 mg of PDLLA acid and 7.5 mg of non-cross-linked hyaluronic acid. By adjusting the amount of the solution and the particle size from 10 to 40 micrometers and combining them with non-cross-linked hyaluronic acid, a hybrid was obtained, adapted to the application of the mesotherapy method on the face, neck, neckline and eye area.
Positive effects can be seen for at least 24 months after two / three treatments performed 6-8 weeks apart. The treatment is especially suitable for people with a large number of fine wrinkles, skin that has lost its radiance, glow and tension, as well as the initial signs of aging.
Warning! For treatments with clear signs of aging, 40+, increasing the volume of sunken areas of the face, especially for the correction of skin cavities such as: folds in the skin, wrinkles, furrows, as well as in the case of face drooping and skin laxity, we recommend the use of Lenisna - it is an acid hybrid polylactic acid PDLLA + HA with a particle size of 50 to 60 micrometers and a volume of 200 mg.
The product may only be used by professionals.
By purchasing the product, you declare that you are a doctor or cosmetologist trained in aesthetic medicine.
There is currently no comments or ratings for this product.